H.C. Wainwright Maintains Buy Rating on MoonLake Immunotherapeutics (MLXT), Keeps PTMay 28, 2025Yahoo Finance
H.C. Wainwright Maintains Buy Rating on Oruka (ORKA) After the Early Start of OKRA-002 TrialMay 28, 2025Yahoo Finance
Eli Lilly Targets Pain Management Opportunity with SiteOne Therapeutics AcquisitionMay 28, 2025Yahoo Finance
Nantucket Jeweler and Marissa Collections Face Legal Fight After Potential Deal DissolvesMay 28, 2025Yahoo Finance
